View allAll Photos Tagged disruptiveInnovation

I was delighted to have the chance to envizualize (create large scale visual notes) for the Disruptive Innovations to Advance Clinical Trials Conference in Boston. From the conference website: "This conference is designed for drug development innovative thinkers who are determined to re-invent clinical trials. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results."

A sustainable and successful innovation process must exist at the intersection of Strategy, Insights, and Capabilities.

Read more at: Compound Innovation Models

I was delighted to have the chance to envizualize (create large scale visual notes) for the Disruptive Innovations to Advance Clinical Trials Conference in Boston. From the conference website: "This conference is designed for drug development innovative thinkers who are determined to re-invent clinical trials. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results."

I was delighted to have the chance to envizualize (create large scale visual notes) for the Disruptive Innovations to Advance Clinical Trials Conference in Boston. From the conference website: "This conference is designed for drug development innovative thinkers who are determined to re-invent clinical trials. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results."

I was delighted to have the chance to envizualize (create large scale visual notes) for the Disruptive Innovations to Advance Clinical Trials Conference in Boston. From the conference website: "This conference is designed for drug development innovative thinkers who are determined to re-invent clinical trials. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results."

I was delighted to have the chance to envizualize (create large scale visual notes) for the Disruptive Innovations to Advance Clinical Trials Conference in Boston. From the conference website: "This conference is designed for drug development innovative thinkers who are determined to re-invent clinical trials. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results."

I was delighted to have the chance to envizualize (create large scale visual notes) for the Disruptive Innovations to Advance Clinical Trials Conference in Boston. From the conference website: "This conference is designed for drug development innovative thinkers who are determined to re-invent clinical trials. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results."

I was delighted to have the chance to envizualize (create large scale visual notes) for the Disruptive Innovations to Advance Clinical Trials Conference in Boston. From the conference website: "This conference is designed for drug development innovative thinkers who are determined to re-invent clinical trials. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results."

Successful organizations (like Apple, Facebook, and Amazon) are not simply innovating along one or two dimensions with their products and services. They have intentionally created compound innovation models to evolve and disrupt the existing experience ecosystem along multiple dimensions simultaneously.

Read more at: Compound Innovation Models

In looking over JISC Strategic document, I think there is something in the innovation matrix that can support a balance of both exploratory and strategic projects for the EXPOSE section, (the Boolean in the Matrix is a quick thought that occurred to me this AM).

 

[cid:image002.png@01CA7A4C.ADB899E0]

 

(1)Incremental Innovation = subtle change to processes and tools i.e. where institutions are somewhat comfortable in spending their own money. #lowRisk #lowGain

 

(2)Semi-Radical Innovation = implementing new practices, i.e. change the ways in which humans do things #Pull #TopDown

 

(3)Semi Radical Innovation = implementing new technology, i.e. change the tools with which humans work #Push #BottomUp

 

(4)Radical Innovation = Change both practice and tools i.e. #HigRisk #HighGain #disruptiveInnovation

 

A = Exploratory projects examining how processes could change

 

B = Strategic projects implementing new technologies to drive change

 

.: overlap in projects that can change both tools and processes are usually the successes. Though as they are projects they must have an "either/or" output focus: projects do better when they have *either* a 'technology' *or* 'process' focus as their project output (both and they end up w too much to manage, i.e. a project manager is usually either good at implementing 'technology change' or 'process change' NOT both at the same time <-- a subtle pattern that seems to be emerging from RI projects that require a short sustained output of either/or?

 

Though, the question then becomes what is a quadrant type "4 - Radical Innovation" project look like, e.g. realising a 'black swan' or 'man on the moon' innovation programme?

 

//ouch my brain just popped after playing around at this level, going back to my budget numbers and call paragraphs :)

Marlon Parker at the Disruptive Innovation discussion

Derek Keats speaks to Minister of Science and Tehcnology, Naledi Pandor

The Disruptive Innovation panel

Naledi Pandor speaks to Derek Keats

Dave Lockwood from the Naledi 3D Factory

Minister Naledi Pandor speaks to DWESA community members

Ronald from ESTIMA speaks to Minister of Science and Tehcnology, Naledi Pandor

Ronald from ESTIMA speaks to Minister of Science and Tehcnology, Naledi Pandor

www.disruptive-innovation.co.uk/design/

 

Product design is an essential part of all product development and innovation processes.

 

Alfredo Terzoli introduces project to the Minister of Science and Technology, Naledi Pandor

Paul Moeng speaks about the value of interactive teaching using Multimedia.

Riyaad speaks about Multimedia maths for CECS

www.disruptive-innovation.co.uk/disruptive-innovation/

 

By designing products that have new meanings for consumers, we can establish new value perceptions in target markets; presenting consumers with overwhelmingly compelling choice drivers and ultimately dominating product markets through these embedded competitive advantages.

 

Our design teams combine advanced innovation methodology with the best practice principals of leading commercial innovators to design and develop products that have truly disruptive potential in target markets.

Louis Coetzee speaks about the Code sprint project

Abdul and Lorraine at the SAFIPA stand

Marlon Parker at the SAFIPA stand speaks to a visitor

Lady from CPUT speaks to a visitor at theSAFIPA stand

Minister in the South African presidency, speaking at InnovaBRICS

 

Suchit Punnose speaking on the panel about disruptive innovation at InnovaBRICS

Technology demolishes tradition

1 3 4 5 6 7 ••• 16 17